Health Care/Hospital
TraceLink Releases Amadeus, the First Generative AI Assistant for Accelerating the Digitalization of Supply Networks on the Opus Platform
Trained on a rich set of information from a unified content repository, Opus Orchestration Architects, Solution Designers, Network Administrators, and those simply interested in learning more about TraceLink's solutions are empowered with information in seconds BOSTON, Oct. 1, 2024 /PRNewswire/ ...
2024-10-01 16:00
1370
Outstanding exhibitor and visitor participation at synergistic co-located exhibitions MEDICAL FAIR ASIA and MEDICAL MANUFACTURING ASIA 2024
* 13,725 attendees from 60 countries attended the exhibitions and concurrent conferences and seminars held over three days * More than 1,000 exhibitors from 45 countries and regions, and 19 national and group pavilions showcased their medical and healthcare solutions * Signature concurrent e...
2024-10-01 10:34
1803
World Top-Performing Incubator Conference 2024 Held in Lingang Shanghai, China
SHANGHAI, Sept. 30, 2024 /PRNewswire/ -- The World Top-Performing Incubator Conference 2024 (WTIF 2024), one of the series activities of Pujiang Innovation Forum, themed "Boundless Innovation, Collaborative Synergy", was held in Lin-gang Special Area,Shanghai from September 26th to 28th, 2024. ...
2024-10-01 09:01
1684
Great Place To Work® Australia and New Zealand names 15 Best Workplaces in Healthcare, Biopharma & Social Assistance in 2024
SYDNEY, Oct. 1, 2024 /PRNewswire/ -- Great Place To Work® ANZ, the global authority on workplace culture today announces theirinaugural 15 Best Workplaces™ in Healthcare, Social Assistance and BioPharma in 2024. The companies are announced across two lists: Best Workplaces in Biotechnology a...
2024-10-01 07:00
8045
Social support becomes lifeline for health amid financial strain
* Study reveals health and vitality is closely linked to mental, social, and physical health. * Financial well-being remains the weakest aspect of well-being, with finance-related concerns as top stressors * High vitality leads to better health management and stronger support networks HONG ...
2024-10-01 00:01
2764
Argon Medical Announces the Expansion of Liver Management Portfolio with Two New Product Introductions
PLANO, Texas, Sept. 30, 2024 /PRNewswire/ -- Argon Medical Devices, a leading provider of medical device solutions for Interventional Radiology, Vascular Surgery, Interventional Cardiology, and Oncology procedures, announced the launch of the Intara™ Introducer Sheath and the TLAB® Transvenous Li...
2024-09-30 21:52
1408
GenEditBio Secures Strategic Investment from Gobi Partners GBA to Accelerate Breakthrough Genome Editing Technologies
HONG KONG, Sept. 30, 2024 /PRNewswire/ -- GenEditBio Limited ("GenEditBio"), a biotech company co-founded by Prof. ZHENG Zongli from the CityUniversity of Hong Kong that focuses on precision genome editing to provide affordable "precision DNA surgery" for genetic diseases with unmet needs, is ple...
2024-09-30 19:36
1761
Digital & Intelligent Pathway: Xiaohongshu and VOGUE Business Unveil Groundbreaking Lifestyle Marketing Insights at Milan Summit
MILAN, Sept. 30, 2024 /PRNewswire/ -- As the exclusive strategic partner, Xiaohongshu teamed up with VOGUE Business to host theThe Digital Silk Road: Pioneering the Future of Luxury Lifestyles summit at Milan's historic Palazzo Serbelloni onSeptember 26-27, 2024. The event aimed to redefine marke...
2024-09-30 16:50
1589
Xiaohongshu x VOGUE Business Unveils New Horizons in Healthcare and Wellness at Milan Summit
MILAN, Sept. 30, 2024 /PRNewswire/ -- From September 26 to 27, Xiaohongshu partnered with VOGUE Business to host theDigital Silk Road: Pioneering the Future of Luxury Lifestyle summit in Milan, Italy. As the exclusive strategic partner, Xiaohongshu gathered global industry leaders on the internat...
2024-09-30 16:30
1271
NUS researchers develop revolutionary technology to unravel complex protein interactions that could transform cancer diagnostics
Scalable and adaptable, TETRIS captures the diversity of protein interactions
on site to inform accurate cancer diagnoses, enabling the personalisation of
ensuing treatments.
SINGAPORE, Sept. 30, 2024 /PRNewswire/ -- A team of researchers from the
National University of Singapore's
2024-09-30 15:51
1360
Doer Biologics Announces First Patient Dosed in Phase 2 Study of DR10624 for Treatment of Severe Hypertriglyceridemia
HANGZHOU, China, Sept. 30, 2024 /PRNewswire/ -- Zhejiang Doer Biologics Co., Ltd. ("Doer Bio"), a clinical stage biopharmaceutical company developing innovative biotherapeutics for metabolic diseases and cancers, today announces that DR10624, its first-in-class (FIC), tri-specific agonist targeti...
2024-09-30 15:00
1064
IASO Bio Scientist and Leading Chinese Physicians in Onco-Hematology Visit Hematology Center at the State University of Campinas, Brazil, to Explore Cooperation in Cancer Treatment
SHANGHAI and NANJING, China and SAN JOSE, Calif., Sept. 30, 2024 /PRNewswire/ -- OnSeptember 23, in Rio de Janeiro, on the eve of the International Myeloma Society (IMS) Annual Meeting, Dr.Yongke Zhang, Chief Scientific Officer of IASO Biotherapeutics (IASO Bio), along with leading Chinese onco-h...
2024-09-30 13:48
1000
Akeso's Cadonilimab Receives Second Indication Approval from NMPA for First-Line Treatment of Gastric/GEJ Cancer in All-Comers Population
HONG KONG, Sept. 30, 2024 /PRNewswire/ -- September 30, 2024, Akeso (9926. HK) announced that its internally developed PD-1/CTLA-4 bispecific antibody, cadonilimab, has received approval from the National Medical Products Administration (NMPA) for a new indication: cadonilimab in combination with...
2024-09-30 13:42
990
World's First Carbon Neutral Salad: The Revolutionary Drinkable Salad that's Good for You and the Planet
HONG KONG, Sept. 29, 2024 /PRNewswire/ -- Tired of sacrificing taste for nutrition? Try Future Salad, the world's first carbon-neutral drinkable salad. It supports a healthy lifestyle and combats climate change. InSeptember 2024, on its 4th anniversary, Future Salad completed a Series A funding r...
2024-09-30 13:22
1551
Regor Enters into a Definitive Purchase Agreement for Genentech to Acquire Regor's Portfolio of next-generation CDK inhibitors for the Treatment of Breast Cancer
* Genentech will acquire Regor's next-generation CDK inhibitors for an upfront payment of$850 million in cash. Regor is also eligible to receive additional cash payments contingent on achieving future development, regulatory and commercial milestones CAMBRIDGE, Mass., Sept. 30, 2024 /PRNewswire...
2024-09-30 13:00
925
Alphamab Oncology and CSPC Achieved a Licensing Agreement on Anti-HER2 Bispecific ADC JSKN003 in Mainland China
SUZHOU, China, Sept. 30, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966 HK) announced that Jiangsu Alphamab Biopharmaceuticals Co., Ltd. ("Alphamab"), a wholly-owned subsidiary of Alphamab Oncology ("the Company"), entered into a licensing agreement (the "Licensing Agreement") on anti-H...
2024-09-30 10:35
3235
Herbalgy 25th Anniversary - Touch Cool- Peppermint Cooling to Soothe Various Pains Anytime, Anywhere
HONG KONG, Sept. 30, 2024 /PRNewswire/ -- Since its establishment in 1999, Herbalgy Pharmaceutical Ltd. has been dedicated to developing products that meet the diverse needs ofHong Kong people. In addition to the "Herbalgy" brand, they have launched two other brands, "Touch Cool" and "Tibet Red,"...
2024-09-30 09:30
1506
Mun Australia Introduces GloveOn COATS® Biodegradable Nitrile Gloves for Enhanced Skin Health and Sustainability
SYDNEY, Sept. 30, 2024 /PRNewswire/ -- Skin irritation is a common concern for workers who frequently wear gloves, and there's an increasing awareness of the need for sustainable product choices. This has led to a growing demand for gloves that not only protect the skin but also minimize environm...
2024-09-30 07:40
1327
SeromYx Systems and ACROBiosystems Announce Strategic Collaboration on Comprehensive Functional Profiling of Anti-CD20 Monoclonal Antibodies
NEWARK, Del., Sept. 29, 2024 /PRNewswire/ -- SeromYx Systems, a cutting-edge immunology technology company, and ACROBiosystems, an innovative provider for life science solutions and tools, are excited to announce the release of their joint study on the comprehensive functional profiling of approv...
2024-09-29 21:00
1267
IASO Bio Presented Comparative Clinical Outcomes on the Optimal Lymphodepletion Prior to Infution of Equecabtagene Autoleucel（FucasoTM）in Patients with Relapsed Refractory Multiple Myeloma at 2024 IMS Annual Meeting
SHANGHAI and NANJING, China and SAN JOSE, Calif, Sept. 29, 2024 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing innovative cell therapy and antibody products, today announced a poster presentati...
2024-09-29 21:00
2210
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Strategic Forum in Chongqing Drives Expansion of New Western Land-Sea Corridor
2024-11-16 14:15
5209
